HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Harjot Othee Selected Research

NTLA-2001

12/2021Transthyretin Amyloid Cardiomyopathy-Current and Future Therapies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Harjot Othee Research Topics

Disease

1Transthyretin-Related Hereditary Amyloidosis
12/2021
1Amyloidosis
12/2021
1Heart Failure
12/2021
1Cardiomyopathies (Cardiomyopathy)
12/2021
1Polyneuropathies (Polyneuropathy)
12/2021
1Disease Progression
12/2021

Drug/Important Bio-Agent (IBA)

1patisiranIBA
12/2021
1InotersenIBA
12/2021
1NTLA-2001IBA
12/2021
1tafamidisIBA
12/2021
1Tolcapone (Tasmar)FDA Link
12/2021
1Amyloid (Amyloid Fibrils)IBA
12/2021
1Prealbumin (Transthyretin)IBA
12/2021
1TeaIBA
12/2021

Therapy/Procedure

1Therapeutics
12/2021